ABSOLUTE cancer genomics (original) (raw)

Nature Biotechnology volume 30, pages 620–621 (2012)Cite this article

Subjects

Calculating absolute copy numbers in cancer genome sequences identifies disease-associated genes and provides insights into tumor evolution and heterogeneity.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Figure 1: Biological insights obtained from sophisticated methods for copy number inference.

References

  1. Carter, S.L. et al. Nat. Biotechnol. 30, 413–421 (2012).
    Article CAS Google Scholar
  2. Kallioniemi, A. et al. Science 258, 818–821 (1992).
    Article CAS Google Scholar
  3. Bignell, G.R. et al. Nature 463, 893–898 (2010).
    Article CAS Google Scholar
  4. Beroukhim, R. et al. Nature 463, 899–905 (2010).
    Article CAS Google Scholar
  5. Popova, T. et al. Genome Biol. 10, R128 (2009).
    Article Google Scholar
  6. Van Loo, P. et al. Proc. Natl. Acad. Sci. USA 107, 16910–16915 (2010).
    Article CAS Google Scholar
  7. Yau, C. et al. Genome Biol. 11, R92 (2010).
    CAS PubMed PubMed Central Google Scholar
  8. Nik-Zainal, S. et al. Cell 149, 994–1007 (2012).
    Article CAS Google Scholar
  9. Gerlinger, M. et al. N. Engl. J. Med. 366, 883–892 (2012)
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. and the Department of Human Genetics, Peter Van Loo is with the Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK, the Center for the Biology of Disease, VIB, Leuven, Belgium, KU Leuven, Leuven, Belgium.,
    Peter Van Loo
  2. the Department of Haematology, and the Department of Haematology, Peter J. Campbell is with the Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK, Addenbrooke's Hospital, Cambridge, UK, University of Cambridge, Cambridge, UK.,
    Peter J Campbell

Authors

  1. Peter Van Loo
    You can also search for this author inPubMed Google Scholar
  2. Peter J Campbell
    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence toPeter Van Loo or Peter J Campbell.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

About this article

Cite this article

Van Loo, P., Campbell, P. ABSOLUTE cancer genomics.Nat Biotechnol 30, 620–621 (2012). https://doi.org/10.1038/nbt.2293

Download citation

This article is cited by